• 1. Fast-pulsing NMR techniques for the detection of weak interactions: successful natural abundance probe of hydrogen bonds in peptides?
  Amandine Altmayer-Henzien,Valérie Declerck,David J. Aitken,Ewen Lescop,Denis Merlet,Jonathan Farjon Org. Biomol. Chem., 2013,11, 7611-7615
• 2. Enantio- & chemo-selective preparation of enantiomerically enriched aliphatic nitro alcohols using Candida parapsilosis ATCC 7330
  Sowmyalakshmi Venkataraman RSC Adv., 2015,5, 73807-73813
• 3. Estimates of hydride ion stability in condensed systems: energy of formation and solvation in aqueous and polar-organic solvents
  Craig A. Kelly,David R. Rosseinsky Phys. Chem. Chem. Phys., 2001,3, 2086-2090
• 4. Excitation dependent bidirectional electron transfer in phthalocyanine-functionalised MoS2 nanosheets?
  Christopher J. Harrison,Kyle J. Berean,Enrico Della Gaspera,Jian Zhen Ou,Richard B. Kaner,Kourosh Kalantar-zadeh,Torben Daeneke Nanoscale, 2016,8, 16276-16283
• 5. Dissociative dynamics of O2 on Ag(110)?
  Ivor Lon?ari? Phys. Chem. Chem. Phys., 2015,17, 9436-9445

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Piperidines Piperidinecarboxylic acids
• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Piperidines Piperidinecarboxylic acids and derivatives Piperidinecarboxylic acids

Recent Advances in the Application of 1,4'-Bipiperidine-1'-carbonyl-1'-carboxylic Acid tert-Butyl Ester (CAS: 125541-12-0) in Chemical Biology and Pharmaceutical Research

The compound 1,4'-Bipiperidine-1'-carbonyl-1'-carboxylic Acid tert-Butyl Ester (CAS: 125541-12-0) has recently garnered significant attention in the field of chemical biology and pharmaceutical research due to its versatile applications as a key intermediate in the synthesis of bioactive molecules. This research brief aims to summarize the latest findings and developments related to this compound, highlighting its role in drug discovery and medicinal chemistry.

Recent studies have demonstrated the utility of 1,4'-Bipiperidine-1'-carbonyl-1'-carboxylic Acid tert-Butyl Ester as a building block for the synthesis of novel piperidine-based scaffolds. These scaffolds are of particular interest due to their presence in a wide range of pharmacologically active compounds, including antipsychotics, analgesics, and anticancer agents. The tert-butyl ester moiety in this compound provides enhanced stability and solubility, making it a preferred choice for synthetic applications.

In a 2023 study published in the Journal of Medicinal Chemistry, researchers utilized 1,4'-Bipiperidine-1'-carbonyl-1'-carboxylic Acid tert-Butyl Ester as a precursor for the development of selective dopamine receptor modulators. The study reported improved binding affinity and selectivity profiles compared to previous analogs, underscoring the compound's potential in central nervous system (CNS) drug development. The researchers employed a combination of molecular docking and structure-activity relationship (SAR) studies to optimize the final compounds.

Another significant application of this compound was reported in the field of anticancer drug discovery. A recent preprint on bioRxiv described its use in the synthesis of novel histone deacetylase (HDAC) inhibitors. The bipiperidine core was found to confer improved pharmacokinetic properties, including enhanced blood-brain barrier penetration, which is crucial for targeting glioblastoma and other CNS malignancies. The study highlighted the compound's role in achieving balanced potency and safety profiles in preclinical models.

From a synthetic chemistry perspective, advancements in the scalable production of 1,4'-Bipiperidine-1'-carbonyl-1'-carboxylic Acid tert-Butyl Ester have been reported. A 2024 patent application disclosed an optimized catalytic process that reduces byproduct formation and improves yield by 30-40%. This development is particularly relevant for industrial-scale pharmaceutical manufacturing, where cost-effectiveness and reproducibility are critical considerations.

Looking ahead, researchers are exploring the potential of this compound in emerging areas such as targeted protein degradation (PROTACs) and covalent inhibitor design. Preliminary results suggest that the bipiperidine scaffold can serve as an effective linker in PROTAC molecules, offering advantages in terms of proteasome recruitment efficiency. These findings position 1,4'-Bipiperidine-1'-carbonyl-1'-carboxylic Acid tert-Butyl Ester as a valuable tool in next-generation therapeutic modalities.

In conclusion, the growing body of research on 1,4'-Bipiperidine-1'-carbonyl-1'-carboxylic Acid tert-Butyl Ester (CAS: 125541-12-0) underscores its importance as a versatile intermediate in medicinal chemistry. Its applications span multiple therapeutic areas, with recent studies demonstrating improvements in drug-like properties and synthetic accessibility. As research continues to evolve, this compound is likely to play an increasingly prominent role in the development of innovative pharmaceutical agents.

• 264905-39-7(tert-butyl 4-(ethylamino)piperidine-1-carboxylate)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)